Why the study?
Cardiac function and structure significantly impact nonischemic heart failure outcomes, motivating an assessment of the relationship between CCTA-derived parameters and clinical outcomes.
Do CCTA-derived parameters (epicardial adipose tissue, peri-coronary adipose, and cardiac muscle mass to lumen volume) predict heart failure readmission in patients with nonischemic heart failure?
Do CCTA-derived parameters (epicardial adipose tissue, peri-coronary adipose, and cardiac muscle mass to lumen volume) predict heart failure readmission in patients with nonischemic heart failure?
CCTA-derived parameters, specifically epicardial adipose tissue volume and cardiac muscle mass to lumen volume ratio, can independently predict short-term readmission in patients with nonischemic heart failure.
CCTA parameters may predict readmission in nonischemic HF; leaves open prospective validation before clinical adoption.
Cardiac function and structure significantly impact nonischemic heart failure (HF) patient outcomes. This study investigated 236 patients (107 nonischemic heart failure, 129 healthy) to assess the relationship between coronary computed tomography angiography (CCTA)-derived parameters and clinical outcomes. Among the nonischemic heart failure patients, 37.3% experienced readmissions. In this group, specific CCTA measurements were identified as significant predictors of readmission: epicardial adipose tissue (CT EAT ) at 54.49 cm 3 (HR: 1.05; 95% CI: 1.03–1.07; P < 0.001), cardiac muscle mass to lumen volume (CT V/M ) at 20% (HR: 0.59; 95% CI: 0.48–0.72; P < 0.001), peri-coronary adipose (CT PCAT ) at -64.68 HU (HR: 1.1; 95% CI: 1.03–1.16; P = 0.002) for the right coronary artery, -81.07 HU (HR: 1.3; 95% CI: 1.1–1.53; P = 0.002) for the left anterior descending artery, and -73.42 HU (HR: 1.33; 95% CI: 1.18–1.51; P < 0.001) for the circumflex branch of the left coronary artery. In patients with nonischemic heart failure, increased CT EAT , CT PCAT , and CT V/M independently predicted rehospitalization.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: